The first 1000 days of a child's life are crucial for the development of their microbiome, which influences everything from immune function to mental health and future disease risks. Historically, understanding of this development has been mostly limited to Western infants, but a new global atlas of baby microbiomes is now offering a broader perspective. Researchers, led by Yan Shao from the Wellcome Sanger Institute in South Cambridge, UK, have sequenced more than 1900 genomes of a bacterium called Bifidobacteria longum, which is associated with the formation of a stable gut microbiome.

Samples were collected from stool specimens obtained in the UK, Sweden, the USA, and seven countries in South Asia, along with Bangladesh, Pakistan, Kenya, Malawi, Burkina Faso, Uganda, and Zimbabwe. The researchers focused on two subspecies of B. longum: B. longum longum and B. longum infantis, which have been the subjects of most previous studies on baby gut microbiomes. By combining their data with a larger pool of microbiome samples, researchers aim to understand better how geography and other factors influence microbiome development in different populations of infants.

This research has critical implications for the treatment of premature babies and could herald new approaches in neonatal care, emphasizing the importance of diverse and geographically representative microbiome data. As researchers continue to explore these dynamics, it could lead to better health outcomes for infants globally, particularly in different social and environmental contexts that have varying impacts on microbiome formation.